Peptidic Partners: A Synergistic Approach to Pharmaceutical Development
Traditionally, drug development has focused on minute molecules, but peptide collaborations are rapidly gaining momentum. This new strategy embraces combining peptides with other biological modalities to tackle complex illness targets. By employing the specific properties of peptidic compounds –